Discontinuation of Biologic Therapy due to Lack/loss of Response and Adverse Events is Similar Between TNFi and non-TNFi Class: Results from a Real-World Rheumatoid Arthritis Cohort
Discontinuation of Biologic Therapy due to Lack/loss of Response and Adverse Events is Similar Between TNFi and non-TNFi Class: Results from a Real-World Rheumatoid Arthritis Cohort
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now